Related Experiment Videos
Melatonin deficiencies in women.
1Department of Gynecology and Obstetrics, University Hospital, Essen, Germany. ufk@uni-essen.de
Maturitas
|April 17, 2002
Summary
Melatonin, a pineal hormone, aids sleep and may help with fibromyalgia and certain depressions. However, its use in contraception and cancer treatment requires further research due to mixed results and potential risks.
Area of Science:
- Endocrinology
- Neuroscience
- Chronobiology
Background:
- Melatonin, a pineal hormone, regulates circadian rhythms and has diverse physiological effects.
- Previous attempts to use melatonin for contraception in women have been unsuccessful.
- Melatonin's role in sleep regulation and its interaction with the gamma-aminobutyric acid (GABA) and benzodiazepine receptor system are key areas of interest.
Purpose of the Study:
- To explore the multifaceted roles of melatonin in human physiology and disease.
- To evaluate melatonin's therapeutic potential in sleep disorders, mood disorders, and other conditions.
- To review evidence regarding melatonin's effects on reproduction, cancer, and metabolic parameters.
Main Methods:
- Review of existing literature on melatonin's physiological effects and clinical applications.
- Analysis of studies investigating melatonin's efficacy in treating insomnia, depression, and fibromyalgia.
- Examination of epidemiological data and experimental studies related to melatonin and cancer risk.
Main Results:
- Melatonin facilitates sleep without hangover and can reduce benzodiazepine dependence.
- Low melatonin levels are associated with fibromyalgia, bulimia, and certain depressive disorders; replacement therapy shows promise.
- Melatonin's efficacy varies across different types of depression; it is most effective for Delayed Sleep Phase Syndrome (DSPS).
- Melatonin influences reproductive hormones and thyroid function in perimenopausal women.
- Evidence suggests potential oncostatic properties and a protective role against certain cancers, particularly in populations with higher melatonin levels (e.g., blind individuals).
- Controversial findings exist regarding melatonin's impact on glucose tolerance and insulin sensitivity, with some studies showing negative effects in postmenopausal women.
- Melatonin is not recommended during pregnancy due to unknown teratogenic effects and for patients with non-hormone-dependent tumors like leukemia.
Conclusions:
- Melatonin holds significant therapeutic potential for sleep disturbances, jet lag, and fibromyalgia.
- Melatonin's role in cancer prevention and treatment requires further investigation.
- Careful consideration of patient population and potential risks is necessary for melatonin's clinical application.